Ann: Atomo receives TGA approval for COVID19 antigen test, page-134

Cash receipts from customers for the three-month period ended 30 September 2020 (Q1
FY21) of $3.04m, up 65% on Q4 FY20 ($1.84m), with the company cash flow positive for
the quarter at the operating activity level, with net positive cash flow of $339k
* Atomo finished the quarter debt-free and with cash on hand of $26.3m
* Continued investment in R&D and manufacturing capacity to meet growing demand for
Atomo’s products , with total unit production capacity increasing to approximately 750,000
per month during the quarter and further expansion under way
* Revenues for Q1 FY21 (unaudited) approximately $2.5m

Not that this means anything to the short term share price. But it's good business.